 | • レポートコード：QY20ST-06115 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のがん免疫療法市場について種類別（モノクローナル抗体（MAB）、癌ワクチン、免疫調節剤、養子細胞移入、チェックポイント阻害剤）、用途別（乳がん、白血病、リンパ腫、黒色腫、結腸直腸がん、非小細胞肺がん）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・がん免疫療法市場の概要 ・世界の主要地域別がん免疫療法市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のがん免疫療法市場規模2015-2026：種類別（モノクローナル抗体（MAB）、癌ワクチン、免疫調節剤、養子細胞移入、チェックポイント阻害剤） ・世界のがん免疫療法市場規模2015-2026：用途別（乳がん、白血病、リンパ腫、黒色腫、結腸直腸がん、非小細胞肺がん） ・がん免疫療法の北米市場規模2015-2020 ・がん免疫療法のヨーロッパ市場規模2015-2020 ・がん免疫療法の中国市場規模2015-2020 ・がん免疫療法の日本市場規模2015-2020 ・がん免疫療法の東南アジア市場規模2015-2020 ・がん免疫療法のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・がん免疫療法の製造コスト分析 ・販売チャネル、流通業者、顧客 ・がん免疫療法の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Cancer Immunotherapies Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Cancer Immunotherapies market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Cancer immunotherapy, also called biologic therapy, which can predominantly be classed as a form of targeted therapy, It is designed to stimulate the body’s immune system to attack tumours.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cancer Immunotherapies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Cancer Immunotherapies industry.
Based on our recent survey, we have several different scenarios about the Cancer Immunotherapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Cancer Immunotherapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Cancer Immunotherapies market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Cancer Immunotherapies market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Cancer Immunotherapies market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Cancer Immunotherapies market. The report also includes nautical information, where it shows Cancer Immunotherapies market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Cancer Immunotherapies market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Cancer Immunotherapies market.
Geographical Analysis:
Based on region, the global Cancer Immunotherapies market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Cancer Immunotherapies market are
Amgen
AstraZeneca
Roche
Bristol-Myers Squibb
Bayer
Merck
ARMO BioSciences (Eli Lilly)
Novartis
Pfizer
Johnson & Johnson
AbbVie
Gilead Sciences
Segment by Type
Monoclonal Antibodies (MABs)
Cancer Vaccines
Immunomodulators
Adoptive Cell transfer
Checkpoint Inhibitors
Segment by Application
Breast Cancer
Leukemia
Lymphoma
Melanoma
Colorectal Cancer
Non-Small Cell Lung Cancer
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Cancer Immunotherapies market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Cancer Immunotherapies market.
• The market share of the global Cancer Immunotherapies market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Cancer Immunotherapies market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Cancer Immunotherapies market.
1 Cancer Immunotherapies Market Overview
1.1 Cancer Immunotherapies Product Scope
1.2 Cancer Immunotherapies Segment by Type
1.2.1 Global Cancer Immunotherapies Sales by Type (2020-2026)
1.2.2 Monoclonal Antibodies (MABs)
1.2.3 Cancer Vaccines
1.2.4 Immunomodulators
1.2.5 Adoptive Cell transfer
1.2.6 Checkpoint Inhibitors
1.3 Cancer Immunotherapies Segment by Application
1.3.1 Global Cancer Immunotherapies Sales Comparison by Application (2020-2026)
1.3.2 Breast Cancer
1.3.3 Leukemia
1.3.4 Lymphoma
1.3.5 Melanoma
1.3.6 Colorectal Cancer
1.3.7 Non-Small Cell Lung Cancer
1.4 Cancer Immunotherapies Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cancer Immunotherapies Sales Growth Rate (2015-2026)
1.4.2 Global Cancer Immunotherapies Revenue and Growth Rate (2015-2026)
1.4.3 Global Cancer Immunotherapies Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Cancer Immunotherapies Industry Impact
1.5.1 How the Covid-19 is Affecting the Cancer Immunotherapies Industry
1.5.1.1 Cancer Immunotherapies Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Cancer Immunotherapies Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Cancer Immunotherapies Players to Combat Covid-19 Impact
2 Cancer Immunotherapies Estimate and Forecast by Region
2.1 Global Cancer Immunotherapies Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cancer Immunotherapies Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cancer Immunotherapies Sales Market Share by Region (2015-2020)
2.2.2 Global Cancer Immunotherapies Revenue Market Share by Region (2015-2020)
2.3 Global Cancer Immunotherapies Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cancer Immunotherapies Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cancer Immunotherapies Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cancer Immunotherapies Estimates and Projections (2015-2026)
2.4.2 Europe Cancer Immunotherapies Estimates and Projections (2015-2026)
2.4.3 China Cancer Immunotherapies Estimates and Projections (2015-2026)
2.4.4 Japan Cancer Immunotherapies Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cancer Immunotherapies Estimates and Projections (2015-2026)
2.4.6 India Cancer Immunotherapies Estimates and Projections (2015-2026)
3 Global Cancer Immunotherapies Competition Landscape by Players
3.1 Global Top Cancer Immunotherapies Players by Sales (2015-2020)
3.2 Global Top Cancer Immunotherapies Players by Revenue (2015-2020)
3.3 Global Cancer Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapies as of 2019)
3.4 Global Cancer Immunotherapies Average Price by Company (2015-2020)
3.5 Manufacturers Cancer Immunotherapies Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cancer Immunotherapies Players (Opinion Leaders)
4 Global Cancer Immunotherapies Market Size by Type
4.1 Global Cancer Immunotherapies Historic Market Review by Type (2015-2020)
4.1.1 Global Cancer Immunotherapies Sales Market Share by Type (2015-2020)
4.1.2 Global Cancer Immunotherapies Revenue Market Share by Type (2015-2020)
4.1.3 Global Cancer Immunotherapies Price by Type (2014-2020)
4.2 Global Cancer Immunotherapies Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cancer Immunotherapies Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Immunotherapies Revenue Forecast by Type (2021-2026)
4.2.3 Global Cancer Immunotherapies Price Forecast by Type (2021-2026)
5 Global Cancer Immunotherapies Market Size by Application
5.1 Global Cancer Immunotherapies Historic Market Review by Application (2015-2020)
5.1.1 Global Cancer Immunotherapies Sales Market Share by Application (2015-2020)
5.1.2 Global Cancer Immunotherapies Revenue Market Share by Application (2015-2020)
5.1.3 Global Cancer Immunotherapies Price by Application (2015-2020)
5.2 Global Cancer Immunotherapies Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cancer Immunotherapies Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Immunotherapies Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Immunotherapies Price Forecast by Application (2021-2026)
3 North America Cancer Immunotherapies Market Facts & Figures
3.2 North America Cancer Immunotherapies Sales Market Share by Company (2015-2020)
3.3 North America Cancer Immunotherapies Sales Market Share by Type (2015-2020)
3.4 North America Cancer Immunotherapies Sales Market Share by Application (2015-2020)
4 Europe Cancer Immunotherapies Market Facts & Figures
4.2 Europe Cancer Immunotherapies Sales Market Share by Company (2015-2020)
4.3 Europe Cancer Immunotherapies Sales Market Share by Type (2015-2020)
4.4 Europe Cancer Immunotherapies Sales Market Share by Application (2015-2020)
5 China Cancer Immunotherapies Market Facts & Figures
5.2 China Cancer Immunotherapies Sales Market Share by Company (2015-2020)
5.3 China Cancer Immunotherapies Sales Market Share by Type (2015-2020)
5.4 China Cancer Immunotherapies Sales Market Share by Application (2015-2020)
6 Japan Cancer Immunotherapies Market Facts & Figures
6.2 Japan Cancer Immunotherapies Sales Market Share by Company (2015-2020)
6.3 Japan Cancer Immunotherapies Sales Market Share by Type (2015-2020)
6.4 Japan Cancer Immunotherapies Sales Market Share by Application (2015-2020)
7 Southeast Asia Cancer Immunotherapies Market Facts & Figures
7.2 Southeast Asia Cancer Immunotherapies Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Cancer Immunotherapies Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Cancer Immunotherapies Sales Market Share by Application (2015-2020)
8 India Cancer Immunotherapies Market Facts & Figures
8.2 India Cancer Immunotherapies Sales Market Share by Company (2015-2020)
8.3 India Cancer Immunotherapies Sales Market Share by Type (2015-2020)
8.4 India Cancer Immunotherapies Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Cancer Immunotherapies Business
12.1 Amgen
12.1.1 Amgen Cancer Immunotherapies Corporation Information
12.1.2 Amgen Cancer Immunotherapies Business Overview and Total Revenue
12.1.3 Amgen Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen Cancer Immunotherapies Products Offered
12.1.5 Amgen Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Cancer Immunotherapies Corporation Information
12.2.2 AstraZeneca Cancer Immunotherapies Business Overview and Total Revenue
12.2.3 AstraZeneca Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AstraZeneca Cancer Immunotherapies Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Roche
12.3.1 Roche Cancer Immunotherapies Corporation Information
12.3.2 Roche Cancer Immunotherapies Business Overview and Total Revenue
12.3.3 Roche Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche Cancer Immunotherapies Products Offered
12.3.5 Roche Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Cancer Immunotherapies Corporation Information
12.4.2 Bristol-Myers Squibb Cancer Immunotherapies Business Overview and Total Revenue
12.4.3 Bristol-Myers Squibb Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bristol-Myers Squibb Cancer Immunotherapies Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Bayer
12.5.1 Bayer Cancer Immunotherapies Corporation Information
12.5.2 Bayer Cancer Immunotherapies Business Overview and Total Revenue
12.5.3 Bayer Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bayer Cancer Immunotherapies Products Offered
12.5.5 Bayer Recent Development
12.6 Merck
12.6.1 Merck Cancer Immunotherapies Corporation Information
12.6.2 Merck Cancer Immunotherapies Business Overview and Total Revenue
12.6.3 Merck Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck Cancer Immunotherapies Products Offered
12.6.5 Merck Recent Development
12.7 ARMO BioSciences (Eli Lilly)
12.7.1 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Corporation Information
12.7.2 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Business Overview and Total Revenue
12.7.3 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.7.4 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Products Offered
12.7.5 ARMO BioSciences (Eli Lilly) Recent Development
12.8 Novartis
12.8.1 Novartis Cancer Immunotherapies Corporation Information
12.8.2 Novartis Cancer Immunotherapies Business Overview and Total Revenue
12.8.3 Novartis Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Novartis Cancer Immunotherapies Products Offered
12.8.5 Novartis Recent Development
12.9 Pfizer
12.9.1 Pfizer Cancer Immunotherapies Corporation Information
12.9.2 Pfizer Cancer Immunotherapies Business Overview and Total Revenue
12.9.3 Pfizer Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Pfizer Cancer Immunotherapies Products Offered
12.9.5 Pfizer Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Cancer Immunotherapies Corporation Information
12.10.2 Johnson & Johnson Cancer Immunotherapies Business Overview and Total Revenue
12.10.3 Johnson & Johnson Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Johnson & Johnson Cancer Immunotherapies Products Offered
12.10.5 Johnson & Johnson Recent Development
12.11 AbbVie
12.11.1 AbbVie Cancer Immunotherapies Corporation Information
12.11.2 AbbVie Cancer Immunotherapies Business Overview and Total Revenue
12.11.3 AbbVie Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AbbVie Cancer Immunotherapies Products Offered
12.11.5 AbbVie Recent Development
12.12 Gilead Sciences
12.12.1 Gilead Sciences Cancer Immunotherapies Corporation Information
12.12.2 Gilead Sciences Cancer Immunotherapies Business Overview and Total Revenue
12.12.3 Gilead Sciences Cancer Immunotherapies Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Gilead Sciences Cancer Immunotherapies Products Offered
12.12.5 Gilead Sciences Recent Development
13 Cancer Immunotherapies Manufacturing Cost Analysis
13.1 Cancer Immunotherapies Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cancer Immunotherapies
13.4 Cancer Immunotherapies Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cancer Immunotherapies Distributors List
14.3 Cancer Immunotherapies Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Cancer Immunotherapies Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Cancer Immunotherapies Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Cancer Immunotherapies Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Cancer Immunotherapies Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Cancer Immunotherapies Players to Combat Covid-19 Impact
Table 8. Global Market Cancer Immunotherapies Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Cancer Immunotherapies Sales (K Units) by Region (2015-2020)
Table 10. Global Cancer Immunotherapies Sales Market Share by Region (2015-2020)
Table 11. Global Cancer Immunotherapies Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Cancer Immunotherapies Revenue Share by Region (2015-2020)
Table 13. Global Cancer Immunotherapies Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Cancer Immunotherapies Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Cancer Immunotherapies Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Cancer Immunotherapies Revenue Share Forecast by Region (2021-2026)
Table 17. Global Cancer Immunotherapies (K Units) of Key Companies (2015-2020)
Table 18. Global Cancer Immunotherapies Sales Share by Company (2015-2020)
Table 19. Global Cancer Immunotherapies Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Cancer Immunotherapies Revenue Share by Company (2015-2020)
Table 21. Global Cancer Immunotherapies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapies as of 2019)
Table 22. Global Cancer Immunotherapies Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Cancer Immunotherapies Manufacturing Sites and Area Served
Table 24. Manufacturers Cancer Immunotherapies Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Cancer Immunotherapies Players
Table 27. Global Cancer Immunotherapies Sales (K Units) by Type (2015-2020)
Table 28. Global Cancer Immunotherapies Sales Share by Type (2015-2020)
Table 29. Global Cancer Immunotherapies Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Cancer Immunotherapies Price (K Units) by Type (2015-2020)
Table 31. Global Cancer Immunotherapies Sales Share by Type (2021-2026)
Table 32. Global Cancer Immunotherapies Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Cancer Immunotherapies Revenue Share by Type (2021-2026)
Table 34. Global Cancer Immunotherapies Price (K Units) by Type (2021-2026)
Table 35. Global Cancer Immunotherapies Sales (K Units) by Application (2015-2020)
Table 36. Global Cancer Immunotherapies Sales Share by Application (2015-2020)
Table 37. Global Cancer Immunotherapies Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Cancer Immunotherapies Price (K Units) by Application (2015-2020)
Table 39. Global Cancer Immunotherapies Sales (K Units) by Application (2021-2026)
Table 40. Global Cancer Immunotherapies Sales Share by Application (2021-2026)
Table 41. Global Cancer Immunotherapies Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Cancer Immunotherapies Revenue Share by Application (2021-2026)
Table 43. Global Cancer Immunotherapies Price (K Units) by Application (2021-2026)
Table 44. United States Cancer Immunotherapies Sales (K Units) by Company (2015-2020)
Table 45. United States Cancer Immunotherapies Sales Market Share by Company (2015-2020)
Table 46. United States Cancer Immunotherapies Sales (K Units) by Type (2015-2020)
Table 47. United States Cancer Immunotherapies Sales Market Share by Type (2015-2020)
Table 48. United States Cancer Immunotherapies Sales (K Units) by Application (2015-2020)
Table 49. United States Cancer Immunotherapies Sales Market Share by Application (2015-2020)
Table 50. Europe Cancer Immunotherapies Sales (K Units) by Company (2015-2020)
Table 51. Europe Cancer Immunotherapies Sales Market Share by Company (2015-2020)
Table 52. Europe Cancer Immunotherapies Sales (K Units) by Type (2015-2020)
Table 53. Europe Cancer Immunotherapies Sales Market Share by Type (2015-2020)
Table 54. Europe Cancer Immunotherapies Sales (K Units) by Application (2015-2020)
Table 55. Europe Cancer Immunotherapies Sales Market Share by Type (2015-2020)
Table 56. China Cancer Immunotherapies Sales (K Units) by Company (2015-2020)
Table 57. China Cancer Immunotherapies Sales Market Share by Company (2015-2020)
Table 58. China Cancer Immunotherapies Sales (K Units) by Type (2015-2020)
Table 59. China Cancer Immunotherapies Sales Market Share by Type (2015-2020)
Table 60. China Cancer Immunotherapies Sales (K Units) by Application (2015-2020)
Table 61. China Cancer Immunotherapies Sales Market Share by Application (2015-2020)
Table 62. Japan Cancer Immunotherapies Sales (K Units) by Company (2015-2020)
Table 63. Japan Cancer Immunotherapies Sales Market Share by Company (2015-2020)
Table 64. Japan Cancer Immunotherapies Sales (K Units) by Type (2015-2020)
Table 65. Japan Cancer Immunotherapies Sales Market Share by Type (2015-2020)
Table 66. Japan Cancer Immunotherapies Sales (K Units) by Application (2015-2020)
Table 67. Japan Cancer Immunotherapies Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Cancer Immunotherapies Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Cancer Immunotherapies Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Cancer Immunotherapies Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Cancer Immunotherapies Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Cancer Immunotherapies Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Cancer Immunotherapies Sales Market Share by Application (2015-2020)
Table 74. India Cancer Immunotherapies Sales (K Units) by Company (2015-2020)
Table 75. India Cancer Immunotherapies Sales Market Share by Company (2015-2020)
Table 76. India Cancer Immunotherapies Sales (K Units) by Type (2015-2020)
Table 77. India Cancer Immunotherapies Sales Market Share by Type (2015-2020)
Table 78. India Cancer Immunotherapies Sales (K Units) by Application (2015-2020)
Table 79. India Cancer Immunotherapies Sales Market Share by Application (2015-2020)
Table 80. Amgen Corporation Information
Table 81. Amgen Description and Business Overview
Table 82. Amgen Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Amgen Cancer Immunotherapies Product
Table 84. Amgen Recent Development
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. AstraZeneca Cancer Immunotherapies Product
Table 89. AstraZeneca Recent Development
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Roche Cancer Immunotherapies Product
Table 94. Roche Recent Development
Table 95. Bristol-Myers Squibb Corporation Information
Table 96. Bristol-Myers Squibb Description and Business Overview
Table 97. Bristol-Myers Squibb Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bristol-Myers Squibb Cancer Immunotherapies Product
Table 99. Bristol-Myers Squibb Recent Development
Table 100. Bayer Corporation Information
Table 101. Bayer Description and Business Overview
Table 102. Bayer Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Bayer Cancer Immunotherapies Product
Table 104. Bayer Recent Development
Table 105. Merck Corporation Information
Table 106. Merck Description and Business Overview
Table 107. Merck Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Merck Cancer Immunotherapies Product
Table 109. Merck Recent Development
Table 110. ARMO BioSciences (Eli Lilly) Corporation Information
Table 111. ARMO BioSciences (Eli Lilly) Description and Business Overview
Table 112. ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Product
Table 114. ARMO BioSciences (Eli Lilly) Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Novartis Description and Business Overview
Table 118. Novartis Cancer Immunotherapies Product
Table 119. Novartis Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Pfizer Description and Business Overview
Table 123. Pfizer Cancer Immunotherapies Product
Table 124. Pfizer Recent Development
Table 125. Johnson & Johnson Corporation Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Johnson & Johnson Cancer Immunotherapies Product
Table 129. Johnson & Johnson Recent Development
Table 130. AbbVie Corporation Information
Table 131. AbbVie Description and Business Overview
Table 132. AbbVie Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. AbbVie Cancer Immunotherapies Product
Table 134. AbbVie Recent Development
Table . Gilead Sciences Corporation Information
Table . Gilead Sciences Description and Business Overview
Table . Gilead Sciences Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Gilead Sciences Cancer Immunotherapies Product
Table . Gilead Sciences Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Cancer Immunotherapies Distributors List
Table 143. Cancer Immunotherapies Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Immunotherapies Product Picture
Figure 2. Global Cancer Immunotherapies Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cancer Immunotherapies Market Share by Application in 2020 & 2026
Figure 6. Breast Cancer Examples
Figure 7. Leukemia Examples
Figure 8. Lymphoma Examples
Figure 9. Melanoma Examples
Figure 10. Colorectal Cancer Examples
Figure 11. Non-Small Cell Lung Cancer Examples
Figure 12. Global Cancer Immunotherapies Sales (K Units) Growth Rate (2015-2026)
Figure 13. Global Cancer Immunotherapies Revenue (US$ Million) Growth Rate (2015-2026)
Figure 14. Global Cancer Immunotherapies Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 15. Global Cancer Immunotherapies Revenue Market Share by Region: 2015 VS 2020
Figure 16. Global Cancer Immunotherapies Revenue Market Share by Region: 2021 VS 2026
Figure 17. United States Cancer Immunotherapies Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. United States Cancer Immunotherapies Sales (K Units) Growth Rate (2015-2026)
Figure 19. Europe Cancer Immunotherapies Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Europe Cancer Immunotherapies Sales (Million USD) Growth Rate (2015-2026)
Figure 21. China Cancer Immunotherapies Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. China Cancer Immunotherapies Sales (Million USD) and Growth Rate (2015-2026)
Figure 23. Japan Cancer Immunotherapies Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Japan Cancer Immunotherapies Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Cancer Immunotherapies Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Cancer Immunotherapies Sales (Million USD) Growth Rate (2015-2026)
Figure 27. India Cancer Immunotherapies Revenue (Million USD) Growth Rate (2015-2026)
Figure 28. India Cancer Immunotherapies Sales (Million USD) Growth Rate (2015-2026)
Figure 29. Global 5 Largest Cancer Immunotherapies Players Market Share by Revenue in Cancer Immunotherapies 2015 & 2019
Figure 30. Cancer Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 31. Global Cancer Immunotherapies Revenue Share by Type (2015-2020)
Figure 32. Global Cancer Immunotherapies Revenue Growth Rate by Type in 2015 & 2019
Figure 33. Global Cancer Immunotherapies Revenue Share by Application (2015-2020)
Figure 34. Global Cancer Immunotherapies Revenue Growth Rate by Application in 2015 & 2019
Figure 35. United States Cancer Immunotherapies Sales Market Share by Type in 2019
Figure 36. United States Cancer Immunotherapies Sales Market Share by Type in 2019
Figure 37. Europe Cancer Immunotherapies Sales Market Share by Company in 2019
Figure 38. Europe Cancer Immunotherapies Sales Market Share by Type in 2019
Figure 39. Europe Cancer Immunotherapies Sales Market Share by Application in 2019
Figure 40. China Cancer Immunotherapies Sales Market Share by Company in 2019
Figure 41. China Cancer Immunotherapies Sales Market Share by Type in 2019
Figure 42. China Cancer Immunotherapies Sales Market Share by Application in 2019
Figure 43. Japan Cancer Immunotherapies Sales Market Share by Company in 2019
Figure 44. Japan Cancer Immunotherapies Sales Market Share by Type in 2019
Figure 45. Japan Cancer Immunotherapies Sales Market Share by Application in 2019
Figure 46. Southeast Asia Cancer Immunotherapies Sales Market Share by Company in 2019
Figure 47. Southeast Asia Cancer Immunotherapies Sales Market Share by Type in 2019
Figure 48. Southeast Asia Cancer Immunotherapies Sales Market Share by Application in 2019
Figure 49. India Cancer Immunotherapies Sales Market Share by Company in 2019
Figure 50. India Cancer Immunotherapies Sales Market Share by Type in 2019
Figure 51. India Cancer Immunotherapies Sales Market Share by Application in 2019
Figure 52. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. ARMO BioSciences (Eli Lilly) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Key Raw Materials Price Trend
Figure 65. Manufacturing Cost Structure of Cancer Immunotherapies
Figure 66. Manufacturing Process Analysis of Cancer Immunotherapies
Figure 67. Cancer Immunotherapies Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Porter's Five Forces Analysis
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
子宮頸癌の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cervical Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cervical Cancer market report…- 子宮頸がん診断検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cervical Cancer Diagnostic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 8198.9 million by 2025, from USD 6937.9 million in 2019. The C…
- 子宮頸がん診断検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cervical Cancer Diagnostic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 8198.9 million by 2025, from USD 6937.9 million in 2019. The C…
- 子宮頸がんワクチンの世界市場レポート2020 Cervical cancer vaccines can effectively prevent cervical cancer in women due to human papillomavirus, and the best age for cervical cancer vaccine injection is 15 years old.Depending on the immunity to the under-15s and over-15s, the cervical cancer vaccine has only a 0.2 per cent chance of develop…
- 腫瘍溶解性ウイルスがん免疫療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Oncolytic Virus Cancer Immunotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncolyti…